Close Menu

NEW YORK (GenomeWeb) – Quebec City-based GenePOC announced today that it has obtained clearance from the US Food and Drug Administration for a small molecular diagnostic panel test to detect carbapenem drug resistance.

The test is the fourth assay on the GenePOC Revogene system, and it detects five gene sequences in carbapenem-producing organisms (CPOs) that are most commonly associated with resistance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.